ERBB2 and breast cancer: Gene expression analyses have provided a new sub-classification of breast cancer patients based on their transcriptomic profile, which allowed them to be originally subclassified into five different molecular breast cancer subtypes: luminal A, luminal B, HER2-positive, normal-like, and basal-like [37].